Article: | MedLuna.com

Overview

Journal Biotechnol Rep (Amst)

Specialty Biotechnology

Date 2024 Jun 17

PMID 38881649

Authors

Rajkumari Urmi

Pallabi Banerjee

Manisha Singh

Risha Singh

Sonam Chhillar

Neha Sharma

Anshuman Chandra

Nagendra Singh

Imteyaz Qamar

Affiliations

Soon will be listed here.

Abstract

With the progress in two distinct areas of nanotechnology and aptamer identification technologies, the two fields have merged to what is known as aptamer nanotechnology. Aptamers have varying properties in the biomedical field include their small size, non-toxicity, ease of manufacturing, negligible immunogenicity, ability to identify a wide range of targets, and high immobilizing capacity. Nevertheless, aptamers can utilize the distinct characteristics offered by nanomaterials like optical, magnetic, thermal, electronic properties to become more versatile and function as a novel device in diagnostics and therapeutics. This engineered aptamer conjugated nanomaterials, in turn provides a potentially new and unique properties apart from the pre-existing characteristics of aptamer and nanomaterials, where they act to offer wide array of applications in the biomedical field ranging from drug targeting, delivery of drugs, biosensing, bioimaging. This review gives comprehensive insight of the different aptamer conjugated nanomaterials and their utilization in biomedical field. Firstly, it introduces on the aptamer selection methods and roles of nanomaterials offered. Further, different conjugation strategies are explored in addition, the class of aptamer conjugated nanodevices being discussed. Typical biomedical examples and studies specifically, related to drug delivery, biosensing, bioimaging have been presented.

Citing Articles

Recent Advances in Aptamers-Based Nanosystems for Diagnosis and Therapy of Cardiovascular Diseases: An Updated Review.

Yu H, Yu J, Yao G Int J Nanomedicine. 2025; 20:2427-2443.

PMID: 40034222 PMC: 11873322. DOI: 10.2147/IJN.S507715.

Microfluidic-SERS sensing system based on dual signal amplification and aptamer for gastric cancer detection.

Huang Y, Chen M, Jiang F, Lu C, Zhu Q, Yang Y Mikrochim Acta. 2024; 191(11):668.

PMID: 39400726 DOI: 10.1007/s00604-024-06760-z.

References

Tuerk C, Gold L . Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249(4968):505-10. DOI: 10.1126/science.2200121. View

Guo X, Zhu X, Gao J, Liu D, Dong C, Jin X . PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma. Nanomedicine (Lond). 2017; 12(21):2611-2624. DOI: 10.2217/nnm-2017-0130. View

Zhen S, Takahashi Y, Narita S, Yang Y, Li X . Targeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome. Oncotarget. 2016; 8(6):9375-9387. PMC: 5354738. DOI: 10.18632/oncotarget.14072. View

Saito S . SELEX-based DNA Aptamer Selection: A Perspective from the Advancement of Separation Techniques. Anal Sci. 2020; 37(1):17-26. DOI: 10.2116/analsci.20SAR18. View

Pei W, Liu M, Wu Y, Zhao Y, Liu T, Sun B . High payload and targeted release of anthracyclines by aptamer-tethered DNA nanotrains - Thermodynamic and release kinetic study. Eur J Pharm Sci. 2020; 148:105319. DOI: 10.1016/j.ejps.2020.105319. View

Tao X, Wang X, Liu B, Liu J . Conjugation of antibodies and aptamers on nanozymes for developing biosensors. Biosens Bioelectron. 2020; 168:112537. DOI: 10.1016/j.bios.2020.112537. View

Zhong L, Cai S, Huang Y, Yin L, Yang Y, Lu C . DNA Octahedron-Based Fluorescence Nanoprobe for Dual Tumor-Related mRNAs Detection and Imaging. Anal Chem. 2018; 90(20):12059-12066. DOI: 10.1021/acs.analchem.8b02847. View

Song P, Ye D, Zuo X, Li J, Wang J, Liu H . DNA Hydrogel with Aptamer-Toehold-Based Recognition, Cloaking, and Decloaking of Circulating Tumor Cells for Live Cell Analysis. Nano Lett. 2017; 17(9):5193-5198. DOI: 10.1021/acs.nanolett.7b01006. View

Li J, Qiu L, Xie S, Zhang J, Zhang L, Liu H . Engineering a customized nanodrug delivery system at the cellular level for targeted cancer therapy. Sci China Chem. 2018; 61(4):497-504. PMC: 6157601. DOI: 10.1007/s11426-017-9176-3. View

10.

Azhdarzadeh M, Atyabi F, Saei A, Shiri Varnamkhasti B, Omidi Y, Fateh M . Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer. Colloids Surf B Biointerfaces. 2016; 143:224-232. DOI: 10.1016/j.colsurfb.2016.02.058. View

11.

Pan Q, Nie C, Hu Y, Yi J, Liu C, Zhang J . Aptamer-Functionalized DNA Origami for Targeted Codelivery of Antisense Oligonucleotides and Doxorubicin to Enhance Therapy in Drug-Resistant Cancer Cells. ACS Appl Mater Interfaces. 2019; 12(1):400-409. DOI: 10.1021/acsami.9b20707. View

12.

Rothlisberger P, Gasse C, Hollenstein M . Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery. Int J Mol Sci. 2017; 18(11). PMC: 5713398. DOI: 10.3390/ijms18112430. View

13.

Guo K, Ziemer G, Paul A, Wendel H . CELL-SELEX: Novel perspectives of aptamer-based therapeutics. Int J Mol Sci. 2009; 9(4):668-678. PMC: 2635693. DOI: 10.3390/ijms9040668. View

14.

Burns J, Seifert A, Fertig N, Howorka S . A biomimetic DNA-based channel for the ligand-controlled transport of charged molecular cargo across a biological membrane. Nat Nanotechnol. 2016; 11(2):152-6. DOI: 10.1038/nnano.2015.279. View

15.

Liu F, Liu X, Shi Q, Maffeo C, Kojima M, Dong L . A tetrahedral DNA nanorobot with conformational change in response to molecular trigger. Nanoscale. 2021; 13(37):15552-15559. DOI: 10.1039/d1nr02757c. View

16.

Pi F, Zhang H, Li H, Thiviyanathan V, Gorenstein D, Sood A . RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery. Nanomedicine. 2016; 13(3):1183-1193. PMC: 5426907. DOI: 10.1016/j.nano.2016.11.015. View

17.

Qian Z, Shan X, Chai L, Chen J, Feng H . A fluorescent nanosensor based on graphene quantum dots-aptamer probe and graphene oxide platform for detection of lead (II) ion. Biosens Bioelectron. 2015; 68:225-231. DOI: 10.1016/j.bios.2014.12.057. View

18.

Kim D, Go M, Lee J, Na D, Yoo S . Recent Advances in Micro/Nanomaterial-Based Aptamer Selection Strategies. Molecules. 2021; 26(17). PMC: 8434002. DOI: 10.3390/molecules26175187. View

19.

Belyanina I, Zamay T, Zamay G, Zamay S, Kolovskaya O, Ivanchenko T . Cancer Cells Elimination Guided by Aptamer-Functionalized Gold-Coated Magnetic Nanoparticles and Controlled with Low Frequency Alternating Magnetic Field. Theranostics. 2017; 7(13):3326-3337. PMC: 5595135. DOI: 10.7150/thno.17089. View

20.

Gomes S, Miguel J, Azema L, Eimer S, Ries C, Dausse E . (99m)Tc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9. Bioconjug Chem. 2012; 23(11):2192-200. DOI: 10.1021/bc300146c. View